AngioDynamics (ANGO) Tops Q2 EPS by 2c; Boosts Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AngioDynamics (ANGO) PT Raised to $21 at Piper Jaffray Amid Strong Q2
January 9, 2015 7:55 AM ESTPiper Jaffray analyst Thomas Gunderson reiterated an Overweight rating and boosted estimate and his price target on AngioDynamics (NASDAQ: ANGO) to $21.00 (from $17.00) following strong Q2 numbers.
Gunderson commented, "ANGO delivered a strong Q2 (Nov) relative to expectations with revenues of $92.1M (up 5%) and... More
